Ohio Public Employees Retirement System (OPERS)
CBIO

Ohio Public Employees Retirement System (OPERS)’s Crescent Biopharma CBIO Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-155
Closed -$47K – 1992
2021
Q1 		$47K Hold
155
– – ﹤0.01% 1888
2020
Q4 		$58K Hold
155
– – ﹤0.01% 1767
2020
Q3 		$48K Hold
155
– – ﹤0.01% 1713
2020
Q2 		$58K Buy
+155
New +$43.9K ﹤0.01% 1638

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s CBIO Position: Q2 2021 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Crescent Biopharma (CBIO) in Q2 2021, closing a stake of 155 shares — an estimated $47K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in CBIO in Q2 2020 and held it in 4 quarters. The position peaked at $58K in Q4 2020. 58 funds tracked by Wall St. Rank hold CBIO as of Q2 2021.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Crescent Biopharma position as of Q2 2021 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 155 Crescent Biopharma shares in Q2 2021, an estimated $47K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Crescent Biopharma in Q2 2020 and held it in 4 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Crescent Biopharma position peaked at $58K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Crescent Biopharma as of Q2 2021.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2021, filed 16 Aug 2021.